Biogen is teaming with Happify on an AI-driven app platform and a digital platform to help MS patients (Happify Health)

Bio­gen leans in­to dig­i­tal ther­a­peu­tics for mul­ti­ple scle­ro­sis, teams with Hap­pi­fy Health

Bio­gen is look­ing out­side its walls for dig­i­tal so­lu­tions to help mul­ti­ple scle­ro­sis pa­tients. Its new part­ner­ship with Hap­pi­fy Health on an MS dig­i­tal ther­a­peu­tic is launch­ing un­der the lead­er­ship of a for­mer CVS Health strate­gist.

Ja­son Haw­beck­er, Bio­gen’s head of strate­gic part­ner­ships, joined the com­pa­ny just over a year ago, af­ter over­see­ing the build­out of CVS’ Covid-19 test­ing plat­form for the phar­ma­cy re­tail­er. He spent sev­en years at CVS in a va­ri­ety of roles in M&A, lead­ing its Aet­na ac­qui­si­tion, launch­ing a CVS health ven­ture fund, and build­ing a part­ner­ships team, sim­i­lar to his role now at Bio­gen.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Venture & Research Associate

Alexandria Real Estate Equities

San Francisco, CA, USA